The effect of metformin on acute phase reactant proteins may be due to its potent anti-inflammatory activity by decreasing NF-kB, reducing insulin resistance, and activating AMPK pathways (Ye et al., 2018). Here, PRKAA1 is linked to Insulin resistance.